Amaterasu® Lifesciences brings together dynamic design methodology and rigorous scientific research. Amaterasu specialises in incremental innovation for developing new topical and injectable drug delivery systems to provide patient benefit.
The SkinEasi® range has been developed by Amaterasu Lifesciences as a part of their constant endeavour to create unique products that fulfil unmet consumer needs using differentiated technology platforms. SkinEasi® is a patented one-of-it’s-kind anti chafing product in India. It’s made keeping the hot and humid tropical Indian Conditions in mind.
The company’s founder, Maharukh T Rustomjee is a leading scientific figure in research and development, pharmaceutical product innovation, product formulation, manufacturing innovation and regulatory sciences. She has an enviable track record of innovations across Formulations and Drug Delivery Systems. In a career spanning 35 years, she has worked with leading organisations like Novartis, Ciba-Geigy, GSK and Burroughs Welcome, going on to co-found Rubicon Research – India’s pioneering contract research and drug delivery company.
She is published widely, authored a book and holds numerous patents. She has spearheaded several drug delivery technology projects, built a strong intellectual property knowledge base, developed strong generics and commercialised patent regime benefits through FTF (First to File) and LCM (Life Cycle Management) opportunities. Maharukh T Rustomjee has won several awards individually and for the organisations she has been associated with and is a leading voice in the Indian and international healthcare and pharmaceutical community.